Brief: Turnstone Biologics Appoints William Waddill To Its Board Of Directors
16/04/2024 14:06
April 16 (Reuters) - Annexon Inc ANNX.O :
* TURNSTONE BIOLOGICS APPOINTS WILLIAM WADDILL TO ITS BOARD
OF
DIRECTORS
Source text for Eikon: ID:nGNX8NMPq5
Further company coverage: ANNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagonist Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI International
US FDA approves Takeda, Protagonist's drug for rare blood cancer (updated)
US FDA approves Takeda, Protagonist's drug for rare blood cancer
Silence Therapeutics jumps after mid-stage trial data for blood cancer drug
Protagonist Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary